Baxter to Present at the 2009 Annual Credit Suisse Health Care Conference
More News related to BAX
- Morgan Keegan Starts BDX, HAE, BCR, MASI, COO at Outperform, BAX, HRC, COV, TFX, ISRG at Market Perform
- 2010 IR Global Rankings: Invitation for Investors and Analysts Vote for Companies with the Best IR Program and for the Best IR Officer
- Baxter (BAX) Raises Qtr Dividend 12% to $0.29/Share, 2.1% Yield
- Baxter Raises Quarterly Dividend
- New Medicare Benefit to Provide Chronic Kidney Disease Patients with Education on Treatment Options
More News related to Press Releases
- Dow Jones, S&P 500 Close Today's Trading Session at Fresh 2009 Highs
- Sign of the Times: U.S. Mint Has To Temporarily Suspend Sales of One Ounce Gold Coins Due to Demand
- Crude Inventories Lower than Expected, Energy Shares Gain Ground (XOM, COP, CVX, MRO, USO, OIL)
- Gold Moves Higher on Weak Dollar, Lower Commodities, Indian Reserve Bank Talk (GLD, ABX, GG, NEM, GDX)
- Novartis (NVS) Excites Incyte (INCY) with Licensing Deal
DEERFIELD, Ill.--(BUSINESS WIRE)-- Baxter International Inc. (NYSE: BAX) announced today that it will present at the 2009 Annual Credit Suisse Health Care Conference on Wednesday, November 11, 2009 at 2:00 p.m. (MST) or 4:00 pm (EST).
The live webcast of Baxter's presentation along with the accompanying slides can be accessed from the Baxter corporate website at www.baxter.com and will be available for replay through December 11, 2009.
Baxter International Inc. develops, manufactures and markets products that save and sustain the lives of people with hemophilia, immune disorders, infectious diseases, kidney disease, trauma, and other chronic and acute medical conditions. As a global, diversified healthcare company, Baxter applies a unique combination of expertise in medical devices, pharmaceuticals and biotechnology to create products that advance patient care worldwide.
Source: Baxter International Inc.
Related Categories
Press ReleasesStocks Mentioned
-0.48Related Entities
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
